Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
The current price of ENVB is $1.34 USD — it has decreased by -1.47% in the past 24 hours. Watch Enveric Biosciences stock price performance more closely on the chart.
What is Enveric Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Enveric Biosciences stocks are traded under the ticker ENVB.
Is Enveric Biosciences stock price growing?▼
ENVB stock has fallen by -0.74% compared to the previous week, the month change is a +4.69% rise, over the last year Enveric Biosciences has showed a -91.54% decrease.
What is Enveric Biosciences market cap?▼
Today Enveric Biosciences has the market capitalization of 5.4M
When is the next Enveric Biosciences earnings date?▼
Enveric Biosciences is going to release the next earnings report on August 17, 2026.
What were Enveric Biosciences earnings last quarter?▼
ENVB earnings for the last quarter are 0.85 USD per share, whereas the estimation was -55.8 USD resulting in a +101.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Enveric Biosciences revenue for the last year?▼
Enveric Biosciences revenue for the last year amounts to 0 USD.
What is Enveric Biosciences net income for the last year?▼
ENVB net income for the last year is -12.13M USD.
Does Enveric Biosciences pay dividends?▼
Yes, ENVB dividends are paid en. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Enveric Biosciences have?▼
As of July 18, 2026, the company has 6 employees.
In which sector is Enveric Biosciences located?▼
Enveric Biosciences operates in the Health & Wellness sector.
When did Enveric Biosciences complete a stock split?▼
The last stock split for Enveric Biosciences was on October 28, 2025 with a ratio of 1:12.
Where is Enveric Biosciences headquartered?▼
Enveric Biosciences is headquartered in Cambridge, United States.